Loading...
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.

PropertyValue
has major subject area list Biomarkers, Tumor; Genetic Predisposition to Disease; Microsatellite Repeats; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Prostatic Neoplasms
information resource reference Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, Ness RB, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Tworoger SS, Whittemore AS, McGuire V, Sieh W, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Rossing MA, Doherty JA, Goodman MT, Carney ME, Lurie G, Wilkens LR, Kj?r SK, H?gdall E, Cramer DW, Terry KL, Garcia-Closas M, Yang H, Lissowska J, Anton-Culver H, Ziogas A, Schildkraut JM, Berchuck A, Pharoah PD. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):1028-31.
label Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.

Search Criteria
  • Cancer